Three clinical trials (ATTACH, RECOVER, and RENAISSANCE) have been performed to test whether TNF inhibitors prevented heart failure (HF) aggravation [75,76]; these trials were conducted with the hypothesis that TNF-α is a pathologic cytokine contributing to HF progression [77]. Here, TNF is linked to hydrops fetalis.